PTC Therapeutics, Inc., a global biopharmaceutical company, announced that the US Food and Drug Administration (FDA) has approved Sephience (sepiapterin) for the treatment of children and adults ...

Bausch Health to acquire DURECT Corporation, strengthening commitment to developing innovative solutions for patients with liver disease: Laval, Quebec Wednesday, July 30, 2025, 1 ...